Growth Metrics

Vycor Medical (VYCO) Long-Term Debt Issuances (2018 - 2023)

Vycor Medical has reported Long-Term Debt Issuances over the past 12 years, most recently at -$1664.0 for Q4 2023.

  • Quarterly Long-Term Debt Issuances rose 96.9% to -$1664.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $61458.0 through Dec 2025, up 697.43% year-over-year, with the annual reading at $59024.0 for FY2025, 3.21% down from the prior year.
  • Long-Term Debt Issuances was -$1664.0 for Q4 2023 at Vycor Medical, down from $63122.0 in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $80000.0 in Q1 2022 and troughed at -$53751.0 in Q4 2022.
  • The 5-year median for Long-Term Debt Issuances is $20700.0 (2019), against an average of $24515.0.
  • The largest YoY upside for Long-Term Debt Issuances was 3571.43% in 2021 against a maximum downside of 83.33% in 2021.
  • A 5-year view of Long-Term Debt Issuances shows it stood at $20000.0 in 2019, then grew by 7.0% to $21400.0 in 2020, then surged by 127.1% to $48600.0 in 2021, then tumbled by 210.6% to -$53751.0 in 2022, then skyrocketed by 96.9% to -$1664.0 in 2023.
  • Per Business Quant, the three most recent readings for VYCO's Long-Term Debt Issuances are -$1664.0 (Q4 2023), $63122.0 (Q3 2023), and -$53751.0 (Q4 2022).